Search

Home > Cell & Gene: The Podcast > TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.
Podcast: Cell & Gene: The Podcast
Episode:

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.
Category: Science & Medicine
Duration: 00:35:30
Publish Date: 2024-07-04 08:00:00
Description:

We love to hear from our listeners. Send us a message.

KSQ Therapeutics' CSO, Micah Benson, Ph.D., joins Erin Harris to discuss how Tumor-Infiltrating Lymphocytes (TILs) as a treatment modality have the potential to treat a variety of solid tumor types. Benson explains KSQ's Phase 1/2 clinical study, KSQ-001EX, which consists of TILs in which the SOCS1 gene is inactivated by CRISPR/Cas9 gene editing. In addition to solid tumors, Benson also addresses the therapeutic potential for autoimmune disease.
Total Play: 0